93 results
SC TO-T
EX-99
LJPC
La Jolla Pharmaceutical Co.
25 Jul 22
Third party tender offer statement
8:34am
% of the outstanding Preferred Shares had agreed in writing to waive all consent and voting rights on behalf of all holders of Preferred Shares with respect
SC TO-C
EX-99.1
ETTX
Entasis Therapeutics Holdings Inc.
23 May 22
Information about tender offer
8:53pm
No Proxies for, Encumbrances on or Disposition of Shares; Transfer of Voting Rights. During the Support Period, except pursuant to the terms of this Agreement
SC TO-C
EX-99.2
ETTX
Entasis Therapeutics Holdings Inc.
23 May 22
Information about tender offer
8:53pm
of Voting Rights. During the Support Period, except pursuant to the terms of this Agreement, Stockholder shall not, without the prior written consent
8-K
EX-99.2
vr8eatfcx7m0bx
23 May 22
Tender and Support Agreement
8:51pm
8-K
EX-99.1
lc4iml
23 May 22
Tender and Support Agreement
8:51pm
8-K
EX-10.5
tjh yw8ssw
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.1
hwe5snrj
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
424B5
x89gux1 ycfkk0f33vgz
18 Jan 13
Prospectus supplement for primary offering
12:00am
S-3ASR
5jxxs5hxnbw vj06pd4
16 Jan 13
Automatic shelf registration
12:00am